Mindmaze Therapeutics HoldinMMTZF

13F holders, Q4 2025 (December 31)
1holders −1
0new positions
1sold out
$2.39avg. 13F price*

At the end of Q4 2025, 1 institutions reported holding Mindmaze Therapeutics Holdin (MMTZF) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holder was Horizon Financial Services, LLC ($184).

Company
Mindmaze Therapeutics Holdin
Filed as
RLFTF (Q4 2025)
CUSIP
H6759S118
Latest filing quarter
Q2 2026

History

Number of 13F holders

012 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 2Q3 2024Q4 2024: 2Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions0$0
Exits1$51

All 13F filers, Q3 2025 → Q4 2025: 12 shares sold, net −12 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Horizon Financial Services, LLC 0.00% No change 77 $184

"% of holder's portfolio" is MMTZF's weight in each manager's 13F, not the share of Mindmaze Therapeutics Holdin the manager owns.